Stocks and Investing Stocks and Investing
Fri, February 18, 2022

Charles Duncan Initiated (VTVT) at Buy and Held Target at $200 on, Feb 18th, 2022


Published on 2024-10-27 19:44:35 - WOPRAI, Charles Duncan
  Print publication without navigation


Charles Duncan of Cantor Fitzgerald, Initiated "vTv Therapeutics Inc." (VTVT) at Buy and Held Target at $200 on, Feb 18th, 2022.

Charles, nor any peers, have made any analyst calls on VTVT in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources